Iron Sucrose Injection shortage
Iron Sucrose Injection is currently listed in shortage by the FDA. The FDA lists 1 affected product. This page was last refreshed from FDA data on Sep 22, 2026.
Mylan Institutional is permanently stopping its iron sucrose injection 50 mg/2.5 mL vial. Other strengths and brands — including Venofer (iron sucrose) and generic versions from several makers — are still listed as available.
Don’t stop or change your therapy on your own — talk with your prescriber about the plan that fits you, and ask your pharmacist what’s actually available (see options).
Do you take this drug? See the ‘What to do’ recommendation from Dr. Brian Staiger, PharmD →What’s in shortage — at a glance
These figures count only the manufacturers that reported this shortage to the FDA — not every company that makes Iron Sucrose Injection. Other makers that haven’t reported a problem are shown in the green card below.
Shortage timeline
-
May 21, 2026Currently in shortage1 of 1 product affected.
-
May 21, 2026First reported to the FDA1 product first listed.
Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.
What exactly is on backorder — by manufacturer
Manufacturer: Mylan Institutional, a Viatris Company 📞 800-796-9526 1 NDC click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| To Be Discontinued | Iron Sucrose, Injection, 50 mg/2.5 mL (NDC 67457-957-99) | — | — | A business decision has been made to discontinue of 2.5mL presentation only. Continuity of supply is forecasted across all other presentations of Iron Sucrose: 67457-639-10 Iron Sucrose 20mg/mL 10mL SDV 5PK 67457-638-10 Iron Sucrose 20mg/mL 5mL SDV 10PK 67457-638-25 Iron Sucrose 20mg/mL 5mL SDV 25PK. | — |
These rows are manufacturer reports to the FDA for Iron Sucrose Injection — they do not necessarily cover every manufacturer that makes this drug. A company appears here only if it told the FDA it has a supply problem, so other makers may still have stock. That’s the basis for the Where else can I get Iron Sucrose Injection? options further down this page.
Why is Iron Sucrose Injection in shortage?
Mylan Institutional (a Viatris company) has made a business decision to permanently stop making one specific size of their Iron Sucrose Injection — the 50 mg/2.5 mL vial. They didn't share a detailed public reason beyond it being a business decision on their end.
The good news is that Mylan says their other Iron Sucrose sizes will continue to be available. Those include:
- Iron Sucrose 20 mg/mL in 10 mL single-dose vials (5-pack)
- Iron Sucrose 20 mg/mL in 5 mL single-dose vials (10-pack)
- Iron Sucrose 20 mg/mL in 5 mL single-dose vials (25-pack)
So it's just that one 2.5 mL package size from this manufacturer that is going away — not their entire Iron Sucrose product line.
Based on the manufacturer-reported reason(s) and notes on file with the FDA for Iron Sucrose Injection, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as manufacturers report changes.
What should I do if I take Iron Sucrose Injection?
Iron Sucrose Injection is currently on the FDA shortage list. I want to walk you through what this means for the strength you may receive.
The strength affected is the 50 mg/2.5 mL presentation, which has no available source reported right now. According to the manufacturer, Mylan Institutional (a Viatris company), this is the result of a business decision to discontinue the 2.5 mL size specifically. Because this is a discontinuation, the supply problem with this particular presentation may be permanent — so a conversation with your prescriber or pharmacist is the right next step.
Importantly, this report reflects one manufacturer's decision about one size. The same medicine, iron sucrose, is still made in other presentations and by other makers.
Here is what I suggest:
- Do not stop, skip, or change your treatment on your own.
- Ask your pharmacy to check wholesalers and other manufacturers — iron sucrose is still listed from makers such as American Regent, Sandoz, Fresenius, and others, though it may not be in local stock.
- If your exact size cannot be found, ask your prescriber or pharmacist about a clinician-chosen option, such as a different presentation to make up the dose.
Manufacturer contact numbers are listed on this page for reference; pharmacies usually handle these calls. This is general national data and may not match your local pharmacy's stock.
- Don’t stop or change the medication on your own — talk to your prescriber first.
- If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
- Ask your pharmacy to check other manufacturers, strengths, package sizes, and nearby stores.
- Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
Uses, dosing, side effects, prices, and the complete FDA label — written in plain English and pharmacist-reviewed.
Where else can I get Iron Sucrose Injection?
FDA shortages are manufacturer-reported — a company only shows up on the shortage list if it told the FDA it has a supply problem, so not every maker of Iron Sucrose Injection is necessarily short. Below we pull together the other still-marketed options that are not reported in shortage: the same medicine from manufacturers that haven’t reported a problem, and alternative dosage forms. These may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.
Same medicine, other manufacturers (not reported short)
Same active ingredient, dosage form & route as the shortage (matched on the FDB HICL ingredient code), from makers that have not filed a shortage with the FDA:
| Product | Strength | Form / route | Manufacturer | NDC |
|---|---|---|---|---|
| Venofer | IRON SUCROSE 20 mg/mL | Injection, Solution · Intravenous | American Regent, Inc. | 00517-2310-05 |
| Iron Sucrose | IRON SUCROSE 50 mg/2.5mL | Injection · Intravenous | Sandoz Inc | 00781-3485-95 |
| Iron Sucrose | IRON SUCROSE 100 mg/5mL | Injection · Intravenous | Sandoz Inc | 00781-3486-95 |
| Venofer | IRON SUCROSE 20 mg/mL | Injection, Solution · Intravenous | Fresenius Medical Care Holdings, Inc. | 49230-0530-10 |
| Iron Sucrose | IRON SUCROSE 100 mg/5mL | Injection, Solution · Intravenous | Mylan Institutional LLC | 67457-0638-10 |
| Iron Sucrose | IRON SUCROSE 200 mg/10mL | Injection, Solution · Intravenous | Mylan Institutional LLC | 67457-0639-10 |
| Iron Sucrose | IRON SUCROSE 20 mg/mL | Injection · Intravenous | International Medication Systems, Limited | 76329-9200-01 |
Therapeutic equivalents & pricing 5 productsclick to expand
Orange Book–rated equivalents of the affected strengths, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.
| Product | Manufacturer | Package | NADAC $/unit | AB rating | Availability |
|---|---|---|---|---|---|
| Venofer 20 mg/mL | American | 10 vials | — | AB | FDA listed |
| Iron Sucrose 50 mg/2.5mL | Sandoz | 10 vials | — | AB | FDA listed |
| Venofer 20 mg/mL | Fresenius | 10 vials | — | AB | FDA listed |
| Iron Sucrose 50 mg/2.5mL | Mylan | 10 vials | — | AB | FDA listed |
| Iron Sucrose 20 mg/mL | International | 10 vials | — | AB | FDA listed |
Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.
Other drugs in the same treatment class
These are different medicines — not other versions of Iron Sucrose Injection — that fall in the same broad treatment class (iron replacement) . They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.
Identity & classification
Where does this data come from?
Other hematology shortages
Iron Sucrose Injection shortage FAQs
Is Iron Sucrose Injection in shortage?
Which products are affected?
When will Iron Sucrose Injection be available again?
Can I still get Iron Sucrose somewhere?
What should I do if I take Iron Sucrose Injection?
Still have a question about the Iron Sucrose Injection shortage?
Ask a pharmacist about this shortage →View Iron Sucrose Injection on the FDA drug-shortage database →
Where does this data come from?
/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (still-marketed manufacturers by ingredient & form); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.